TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16416305

Group type: EXPERIMENTAL
Intervention: Grapefruit juice (GFJ) with 0.25 mg triazolam
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Grapefruit juice (GFJ) with 15 mg quazepam
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control (0.25 mg triazolam without GFJ)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control (15 mg quazepam without GFJ)
Number of subjects: 9
Study: 15018412

Group type: EXPERIMENTAL
Intervention: Ultrasonic scalpel
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional instruments
Number of subjects: 30
Study: 11188859

Group type: EXPERIMENTAL
Intervention: New randomized ablation pattern (OS)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Older sequential pattern (OS)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: New randomized ablation pattern (OD)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both patterns (OD and OS)
Number of subjects: 16
Study: 8847321

Group type: EXPERIMENTAL
Intervention: New noninvasive blood pressure measurement method
Number of subjects: 26

Group type: COMPARATOR
Intervention: Sphygmomanometry
Number of subjects: 26
Study: 1556276

Group type: EXPERIMENTAL
Intervention: relaxation plus coping self-efficacy (SE) enhancement
Number of subjects: 48

Group type: COMPARATOR
Intervention: relaxation only
Number of subjects: 48

Group type: COMPARATOR
Intervention: procedural information
Number of subjects: 48

Group type: COMPARATOR
Intervention: no preparation
Number of subjects: 48
Study: 4029406

Group type: EXPERIMENTAL
Intervention: Radiotherapy for glottic T1N0 tumours
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Supra-glottic laryngectomy and prophylactic neck dissection for supra-glottic T1N0 tumours (first 7 years)
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Radiotherapy for supra-glottic T1N0 tumours (after first 7 years)
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Salvage surgery for failed radiotherapy or surgery for supra-glottic carcinoma
Number of subjects: 900
Study: 31937103

Group type: EXPERIMENTAL
Intervention: Dietary intervention (Mediterranean and low-fat)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Postprandial glucagon levels
Number of subjects: 0
Study: 31046695

Group type: EXPERIMENTAL
Intervention: Point-of-care viral load monitoring
Number of subjects: 794

Group type: COMPARATOR
Intervention: Standard-of-care viral load monitoring
Number of subjects: 794
Study: 30121304

Group type: EXPERIMENTAL
Intervention: Aerobic training (n=10)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Resistance training (n=11)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Both aerobic and resistance training
Number of subjects: 21
Study: 26943948

Group type: EXPERIMENTAL
Intervention: HOBSCOTCH program with additional working memory training (H+)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: HOBSCOTCH program without additional working memory training (H)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Waitlisted control group
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: HOBSCOTCH program (H+ and H)
Number of subjects: 66
Study: 23678929

Group type: EXPERIMENTAL
Intervention: Jobs First welfare reform program
Number of subjects: 4612

Group type: COMPARATOR
Intervention: Traditional welfare (Aid to Families with Dependent Children)
Number of subjects: 4612
Study: 22297271

Group type: EXPERIMENTAL
Intervention: tramadol+dexamethasone
Number of subjects: 30

Group type: COMPARATOR
Intervention: tramadol+diclofenac sodium
Number of subjects: 30
Study: 19345072

Group type: EXPERIMENTAL
Intervention: Mirtazapine (30 mg/day)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Paroxetine (20 mg/day)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Combination of mirtazapine and paroxetine
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 61

Group type: COMPARATOR
Intervention: Non-responders on monotherapy
Number of subjects: 61
Study: 17762217

Group type: EXPERIMENTAL
Intervention: Bismuth subgallate/borneol (Suile)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Bacitracin (control)
Number of subjects: 20
Study: 15722985

Group type: EXPERIMENTAL
Intervention: Oral polybacterial lysate suspension
Number of subjects: 83

Group type: COMPARATOR
Intervention: No-treatment clinical follow-up (control group)
Number of subjects: 83
Study: 12069142

Group type: EXPERIMENTAL
Intervention: Intravaginal misoprostol 400 micrograms (two tablets of 200 micrograms each)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo (two tablets of vaginal placebo)
Number of subjects: 54
Study: 10412244

Group type: EXPERIMENTAL
Intervention: Irradiated polyglactin 910 (IRPG) Vicryl Rapide sutures
Number of subjects: 113

Group type: COMPARATOR
Intervention: Polytetrafluoroethylene (PTFE) sutures
Number of subjects: 113

Group type: COMPARATOR
Intervention: Traditional polyglycolic acid (PGLA) sutures
Number of subjects: 113

Group type: COMPARATOR
Intervention: Skin staples
Number of subjects: 113
Study: 7671893

Group type: EXPERIMENTAL
Intervention: Plasma ANP analysis
Number of subjects: 31
Study: 2073911

Group type: EXPERIMENTAL
Intervention: Gemfibrozil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 7241106

Group type: EXPERIMENTAL
Intervention: Superimposed slide presentation
Number of subjects: 43

Group type: COMPARATOR
Intervention: Separated slide presentation (control)
Number of subjects: 43
Study: 6742393

Group type: EXPERIMENTAL
Intervention: Midline approach
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Paramedian approach
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 28715272

Group type: EXPERIMENTAL
Intervention: Face-to-Face Behavioral Parent Training (F2F)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Online Behavioral Parent Training (Online BPT)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Waitlist Control (WLC)
Number of subjects: 47
Study: 27672029

Group type: EXPERIMENTAL
Intervention: Pentolinium (nicotinic ganglion blocker)
Number of subjects: 368

Group type: EXPERIMENTAL
Intervention: Isometric handgrip exercise
Number of subjects: 368

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 368
Study: 25080920

Group type: EXPERIMENTAL
Intervention: Critical care ventilator with pressure‐synchronized intermittent mandatory ventilation (P‐SIMV) + PSV + PEEP (Group C)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Critical care ventilator with pressure support ventilation and positive end expiratory pressure (PSV + PEEP; Group B)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Miniventilator with BiLevel positive airway pressure (BiPAP; Group A)
Number of subjects: 63
Study: 22337287

Group type: EXPERIMENTAL
Intervention: PEG‐IFN2a (90 mcg escalating to 180 mcg weekly for 48 weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard clinical care (no further antiviral therapy)
Number of subjects: 40
Study: 20236841

Group type: EXPERIMENTAL
Intervention: Vein collar
Number of subjects: 352

Group type: COMPARATOR
Intervention: No vein collar
Number of subjects: 352
Study: 18713253

Group type: EXPERIMENTAL
Intervention: Bortezomib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dexamethasone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bortezomib + Dexamethasone +/− Erythropoietin
Number of subjects: 0
Study: 15785283

Group type: EXPERIMENTAL
Intervention: Ropivacaine
Number of subjects: 24

Group type: COMPARATOR
Intervention: Bupivacaine
Number of subjects: 24
Study: 11896977

Group type: EXPERIMENTAL
Intervention: Topical repifermin (recombinant human keratinocyte growth factor-2) applied for 12 weeks
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study: 9448627

Group type: EXPERIMENTAL
Intervention: Open haemorrhoidectomy
Number of subjects: 67

Group type: COMPARATOR
Intervention: Closed haemorrhoidectomy
Number of subjects: 67
Study: 8305264

Group type: EXPERIMENTAL
Intervention: Duplex Doppler sonography (DDS)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Angiography
Number of subjects: 22
Study: 2851877

Group type: EXPERIMENTAL
Intervention: 5 mg/kg/day ganciclovir
Number of subjects: 11

Group type: COMPARATOR
Intervention: 10 mg/kg/day ganciclovir
Number of subjects: 11
Study: 31630398

Group type: EXPERIMENTAL
Intervention: Inhaled nitrous oxide (50:50 mix with oxygen)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Medical air
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Inhaled nitrous oxide (50:50 mix with oxygen) among parous women
Number of subjects: 150

Group type: COMPARATOR
Intervention: Medical air among parous women
Number of subjects: 150
Study: 30136589

Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT) for 2 weeks postoperatively
Number of subjects: 68

Group type: COMPARATOR
Intervention: Standard postoperative physiotherapy (breathing exercises, coughing techniques, early mobilization)
Number of subjects: 68
Study: 26831892

Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 94

Group type: COMPARATOR
Intervention: Standard low fat diet
Number of subjects: 94
Study: 24532260

Group type: EXPERIMENTAL
Intervention: Pomegranate extract (PE) consumers (900 mg/day for 15 days)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Pomegranate extract (PE-1)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Pomegranate extract (PE-2)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Urolithin A or isourolithin A
Number of subjects: 52
Study: 23110382

Group type: EXPERIMENTAL
Intervention: Self-report measures covering general health, self-management, emotional well-being, and contact with health care providers
Number of subjects: 3960

Group type: EXPERIMENTAL
Intervention: Five complementary modules allocated randomly to participants
Number of subjects: 3960
Study: 19493959

Group type: EXPERIMENTAL
Intervention: Mirtazapine treatment for 8 weeks
Number of subjects: 243
Study: 17535542

Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT)
Number of subjects: 10
Study: 16108399

Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (rHuEPO) plus iron supplementation for ten days before surgery and five days postoperatively
Number of subjects: 38

Group type: COMPARATOR
Intervention: Iron supplementation only
Number of subjects: 38
Study: 12086353

Group type: EXPERIMENTAL
Intervention: Alendronate and calcium
Number of subjects: 150

Group type: COMPARATOR
Intervention: Calcium alone
Number of subjects: 150
Study: 9815866

Group type: EXPERIMENTAL
Intervention: Aspirin 250 mg and Ticlopidine 500 mg/d (A+T group)
Number of subjects: 350

Group type: COMPARATOR
Intervention: Aspirin 250 mg/d and oral anticoagulation (A+OAC group)
Number of subjects: 350
Study: 8596098

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 129

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 129
Study: 2698587

Group type: EXPERIMENTAL
Intervention: Hemodilution with repeated venesections (total 250-1000 ml) and concomitant dextran 40 administration
Number of subjects: 485

Group type: COMPARATOR
Intervention: Control group (no hemodilution)
Number of subjects: 485

Group type: EXPERIMENTAL
Intervention: Hemodilution
Number of subjects: 485
Study: 1124532

Group type: EXPERIMENTAL
Intervention: 10 mg oral delta‐1‐(trans)‐tetrahydrocannabinol
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: salbutamol
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: oral delta‐1‐(trans)‐tetrahydrocannabinol
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: delta‐1‐(trans)‐tetrahydrocannabinol
Number of subjects: 16
Study: 31658381

Group type: EXPERIMENTAL
Intervention: AJM300 960 mg
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: AJM300 240 mg
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: AJM300 480 mg
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 30691468

Group type: EXPERIMENTAL
Intervention: Umeclidinium bromide/vilanterol 62.5/25 mcg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tiotropium/olodaterol 5/5 mcg
Number of subjects: 0
Study: 29544572

Group type: EXPERIMENTAL
Intervention: Metformin alone
Number of subjects: 108

Group type: COMPARATOR
Intervention: Metformin plus Simvastatin
Number of subjects: 108
Study: 26388147

Group type: EXPERIMENTAL
Intervention: Ketamine (acute, subanaesthetic doses)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 0
Study: 24629823

Group type: EXPERIMENTAL
Intervention: Fentanyl 1 μg/kg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 100
Study: 22079151

Group type: EXPERIMENTAL
Intervention: Augment strategy (n=269)
Number of subjects: 538

Group type: COMPARATOR
Intervention: Switch strategy (n=269)
Number of subjects: 538
Study: 18166179

Group type: EXPERIMENTAL
Intervention: Anastrozole (1 mg/d for 5 days starting on day 3 of menses; 115 patients, 243 cycles)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Clomiphene citrate (CC; 100 mg/d; 101 patients, 226 cycles)
Number of subjects: 216
Study: 17785984

Group type: EXPERIMENTAL
Intervention: 3-stitch purse-string suture
Number of subjects: 90

Group type: COMPARATOR
Intervention: 6-stitch purse-string suture
Number of subjects: 90
Study: 14981835

Group type: EXPERIMENTAL
Intervention: Low-dose helical CT with 10 mm collimation
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Low-dose helical CT with 8 mm collimation
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Low-dose helical CT with 5 mm collimation
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Sequential subsection scan of chest with 50 mA and 8 mm collimation
Number of subjects: 40
Study: 12476289

Group type: EXPERIMENTAL
Intervention: ganciclovir
Number of subjects: 91

Group type: COMPARATOR
Intervention: acyclovir
Number of subjects: 91
Study: 10099946

Group type: EXPERIMENTAL
Intervention: Detraining group (stop normal training but continue activities of daily living)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (continue normal training)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Detraining group
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Detraining group and Control group
Number of subjects: 16
Study: 7546784

Group type: EXPERIMENTAL
Intervention: Dobutamine stress echocardiography
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Dipyridamole stress echocardiography
Number of subjects: 46

Group type: COMPARATOR
Intervention: Both dobutamine and dipyridamole stress echocardiography
Number of subjects: 46
Study: 1971751

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Pindolol
Number of subjects: 50
Study: 698606

Group type: EXPERIMENTAL
Intervention: Ambulant group
Number of subjects: 68

Group type: COMPARATOR
Intervention: Recumbent group
Number of subjects: 68
Study: 31864166

Group type: EXPERIMENTAL
Intervention: Inhibitory-control training to cocaine images
Number of subjects: 40

Group type: COMPARATOR
Intervention: Neutral image training
Number of subjects: 40
Study: 30927159

Group type: EXPERIMENTAL
Intervention: 300 mg PEA
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: 600 mg PEA
Number of subjects: 111

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study: 27862837

Group type: EXPERIMENTAL
Intervention: Motivational interviewing
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Lecture
Number of subjects: 230

Group type: COMPARATOR
Intervention: Control
Number of subjects: 230
Study: 26354213

Group type: EXPERIMENTAL
Intervention: Stem Cell Therapy (SCT) - infusion of 5-10 × 10^8 autologous mononuclear cells (MNC) by intra-coronary route
Number of subjects: 250

Group type: COMPARATOR
Intervention: Standard Medical Therapy (non SCT group)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Stem Cell Therapy (SCT) with cell dose ≥ 5 × 10^8 (n=71)
Number of subjects: 250
Study: 23932151

Group type: EXPERIMENTAL
Intervention: Oropharyngeal mycosis (OPM) cases during radiotherapy
Number of subjects: 410
Study: 20346621

Group type: EXPERIMENTAL
Intervention: Low-pass filter cutoff frequency of 300 Hz or higher
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-pass filter cutoff frequency of 100 Hz
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-pass filter cutoff frequency of 300 Hz
Number of subjects: 0
Study: 19731228

Group type: EXPERIMENTAL
Intervention: Iron sucrose (600 mg intravenously in two divided doses, at least 24 hours apart, 14 days before surgery)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (given intravenously in two divided doses, at least 24 hours apart, 14 days before surgery)
Number of subjects: 60
Study: 17679132

Group type: EXPERIMENTAL
Intervention: HbA1c levels
Number of subjects: 26563
Study: 15559735

Group type: EXPERIMENTAL
Intervention: Parent-based intervention to prevent skin cancer
Number of subjects: 340

Group type: COMPARATOR
Intervention: Control group (129 children)
Number of subjects: 340
Study: 11312473

Group type: EXPERIMENTAL
Intervention: Sevoflurane 8% (n = 12)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Etomidate 0.2 to 0.3 mg/kg (n = 10)
Number of subjects: 22
Study: 9726264

Group type: EXPERIMENTAL
Intervention: Inpatient treatment
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Intense outpatient treatment
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Standard outpatient treatment
Number of subjects: 302

Group type: COMPARATOR
Intervention: Decliners (control group)
Number of subjects: 302
Study: 1599887

Group type: EXPERIMENTAL
Intervention: Continuous infusion of 20 ml 0.375% bupivacaine with 1:200,000 epinephrine at a rate of 6 ml/hour during the first 24 hours postoperatively
Number of subjects: 80

Group type: COMPARATOR
Intervention: Bolus administration of 20 ml 0.375% bupivacaine with 1:200,000 epinephrine at four-hour intervals
Number of subjects: 80
Study: 3904335

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 162

Group type: COMPARATOR
Intervention: Bendroflumethiazide
Number of subjects: 162
Study: 31666259

Group type: EXPERIMENTAL
Intervention: Tryptophan
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Phenylalanine
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Combination of tryptophan and phenylalanine
Number of subjects: 112

Group type: COMPARATOR
Intervention: Combination of AAs
Number of subjects: 112
Study: 29788136

Group type: EXPERIMENTAL
Intervention: FertiEduc group (fertility information)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Control group (healthy pregnancy information)
Number of subjects: 208
Study: 27692842

Group type: EXPERIMENTAL
Intervention: TX-004HR 10 μg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TX-004HR 25 μg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TX-004HR 4 μg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 24484540

Group type: EXPERIMENTAL
Intervention: Three-band RDT
Number of subjects: 1648

Group type: COMPARATOR
Intervention: HRP2 alone
Number of subjects: 1648

Group type: COMPARATOR
Intervention: Microscopy
Number of subjects: 1648
Study: 21721988

Group type: EXPERIMENTAL
Intervention: Porcine collagen matrix (PCM) plus coronally advanced flap (CAF)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Connective tissue graft (CTG) plus coronally advanced flap (CAF)
Number of subjects: 18
Study: 19617849

Group type: EXPERIMENTAL
Intervention: Nevirapine (NVP)
Number of subjects: 610

Group type: COMPARATOR
Intervention: Zidovudine
Number of subjects: 610

Group type: EXPERIMENTAL
Intervention: Maternal viral load (pre-entry)
Number of subjects: 610

Group type: EXPERIMENTAL
Intervention: CD4 cell count
Number of subjects: 610

Group type: EXPERIMENTAL
Intervention: Maternal viral load (6-8 weeks)
Number of subjects: 610

Group type: EXPERIMENTAL
Intervention: Maternal NVP resistance (6-8 weeks)
Number of subjects: 610
Study: 17276786

Group type: EXPERIMENTAL
Intervention: Supplemental training using visual demonstration of respiratory particle dispersion
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard classroom training
Number of subjects: 20
Study: 15382120

Group type: EXPERIMENTAL
Intervention: TIPS (transjugular intrahepatic portosystemic shunt)
Number of subjects: 116

Group type: COMPARATOR
Intervention: HR-non-TIPS group
Number of subjects: 116
Study: 11156638

Group type: EXPERIMENTAL
Intervention: Budesonide 6 mg once daily
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 9685100

Group type: EXPERIMENTAL
Intervention: Chlorpheniramine maleate (CM) 4mg
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 9139377

Group type: EXPERIMENTAL
Intervention: Nakayama strain JE vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Beijing strain JE vaccine
Number of subjects: 0
Study: 2198921

Group type: EXPERIMENTAL
Intervention: Oxybutynin chloride
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 352700

Group type: EXPERIMENTAL
Intervention: Sotalol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Atropine and Sotalol
Number of subjects: 0
Study: 31232512

Group type: EXPERIMENTAL
Intervention: Full-size family ration with individual ration of corn-soy blend or micronutrient powder in Guatemala; lowest cost per percentage point reduction in stunting.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Food assistance for the full 1,000 days in Burundi; lowest cost per percentage point reduction in stunting.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reduced duration of ration eligibility in Burundi; less effective than full duration.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Two-year extension of the program in Guatemala; potential savings of 11% per beneficiary.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Two-year extension of the program in Burundi; potential savings of 18% per beneficiary.
Number of subjects: 0
Study: 28630081

Group type: EXPERIMENTAL
Intervention: Cinacalcet treatment
Number of subjects: 3883

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3883
Study: 26188787

Group type: EXPERIMENTAL
Intervention: Subacromial decompression with bursectomy and arthroscopic removal of calcific deposit
Number of subjects: 80

Group type: COMPARATOR
Intervention: Bursectomy and arthroscopic removal of calcific deposit without subacromial decompression
Number of subjects: 80
Study: 23183639

Group type: EXPERIMENTAL
Intervention: (S)-ketamine (serum target 50 ng/ml)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: (S)-ketamine (serum target 10 ng/ml)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: (S)-ketamine (serum target 30 ng/ml)
Number of subjects: 11